Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 77Terminated 20Recruiting 15Active not recruiting 11Withdrawn 4Unknown 4Suspended 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neuroblastoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Advanced Glioblastoma 1

Interventions

venetoclax 25Azacitidine 23Cytarabine 12fludarabine 11Specimen Handling 9Biopsy 7Busulfan 6Melphalan 5Daunorubicin 5Thiotepa 4Decitabine 4Cyclophosphamide 4selinexor 3olutasidenib 3gilteritinib 3Whole-Body Irradiation 3Tacrolimus 3Idarubicin 3Homoharringtonine 3treosulfan 2revumenib 2fludarabine phosphate 2decitabine and cedazuridine drug combination 2Stem Cell Transplantation 2Maintenance 2Lymphatic Irradiation 2Leukapheresis 2Injections 2Granulocyte Colony-Stimulating Factor 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Myeloid, Acute × Mycophenolic Acid × Clear all
NCT07548983 2026-04-23

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

OHSU Knight Cancer Institute

Phase 1 Not yet recruiting
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡